Noncholinesterase mechanisms of chlorpyrifos neurotoxicity: altered phosphorylation of Ca2+/cAMP response element binding protein in cultured neurons.
Previous studies suggest that low doses of the organophosphate insecticide chlorpyrifos (CPF) disrupt brain development and cognitive function by mechanisms that do not involve the inhibition of acetylcholinesterase (AChE). In the present study we tested the hypothesis that CPF and its metabolites alter the Ca2+/cAMP response element binding protein (CREB), a critical molecule in brain development and cognitive function. We further tested the hypothesis that changes in CREB occur independent of AChE inhibition. Western blot analysis of lysates from primary cultures of cortical neurons exposed to CPF, CPF-oxon, or trichloropyridinol (TCP) for 1 h and cultures exposed to trichloropyridinol (TCP) for 7 days indicated that all exposures increased the level of the phosphorylated (activated) form of CREB (pCREB), without significant changes in total CREB or alpha-tubulin. Remarkably, pCREB in cortical neurons was elevated by 300-400% of control levels with estimated EC50s of 60 pM, <30 fM, and <30 pM for CPF, CPF-oxon, and TCP, respectively. AChE activity and cell viability were not affected by organophosphate concentrations that caused significant increases in pCREB (up to 100 nM, 100 pM, and 10 microM of CPF, CPF-oxon, and TCP, respectively). The level of pCREB in hippocampal neurons was also elevated after exposure to CPF, but pCREB in cultured astrocytes was not affected. Inclusion of the cytochrome P-450 inhibitor SKF-525A did not inhibit the effects of CPF on pCREB levels, indicating that metabolism of CPF to CPF-oxon was not necessary to cause the increase in pCREB. The increases in neuronal pCREB observed in this study provide biochemical evidence that CPF and its metabolites are active at critical sites within the nervous system at levels far below those required to inhibit AChE, which could explain many of the reported neurodevelopmental and behavioral changes attributed to CPF toxicity.
Schuh
Rosemary A
RA
Department of Environmental Health Science, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 21205, USA.
Lein
Pamela J
PJ
Beckles
Rondell A
RA
Jett
David A
DA
D000110:Acetylcholinesterase / Q000378:metabolism; D000818:Animals; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism; D015153:Blotting, Western; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D004390:Chlorpyrifos / Q000633:toxicity*; D017362:Cyclic AMP Response Element-Binding Protein / Q000378:metabolism*; D006624:Hippocampus / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D007306:Insecticides / Q000633:toxicity*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D020258:Neurotoxicity Syndromes / Q000473:pathology*; D010766:Phosphorylation; D051381:Rats
D017362:Cyclic AMP Response Element-Binding Protein; D007306:Insecticides; D000110:Acetylcholinesterase; D004390:Chlorpyrifos